Financial Ratios ICICI Prudential Life Insurance Company Limited
Equities
ICICIPRULI
INE726G01019
Life & Health Insurance
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
650.60 INR | -2.84% |
|
-4.37% | -0.65% |
Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.42 | 0.28 | 0.29 | 0.25 | 0.35 | |||||
Return on Total Capital | 8.93 | 6.31 | 6.74 | 5.91 | 7.93 | |||||
Return On Equity % | 11.72 | 8.31 | 8.45 | 8.07 | 10.34 | |||||
Return on Common Equity | 11.72 | 8.31 | 8.45 | 8.07 | 10.34 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 5.54 | 8.67 | 12.98 | 6.57 | 8.98 | |||||
SG&A Margin | 3.22 | 5.87 | 9.24 | 4.58 | 5.58 | |||||
EBITDA Margin % | 1.56 | 1.75 | 2.47 | 1.31 | 2.5 | |||||
EBITA Margin % | 1.5 | 1.67 | 2.36 | 1.24 | 2.39 | |||||
EBIT Margin % | 1.5 | 1.67 | 2.36 | 1.24 | 2.39 | |||||
Income From Continuing Operations Margin % | 1.15 | 1.22 | 1.65 | 0.95 | 1.67 | |||||
Net Income Margin % | 1.15 | 1.22 | 1.65 | 0.95 | 1.67 | |||||
Net Avail. For Common Margin % | 1.15 | 1.22 | 1.65 | 0.95 | 1.67 | |||||
Normalized Net Income Margin | 0.92 | 0.96 | 1.37 | 0.71 | 1.39 | |||||
Levered Free Cash Flow Margin | 0.7 | 1.56 | 0.86 | -0.74 | -1.03 | |||||
Unlevered Free Cash Flow Margin | 0.72 | 1.64 | 0.96 | -0.68 | -0.93 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.45 | 0.27 | 0.2 | 0.32 | 0.23 | |||||
Fixed Assets Turnover | 187.2 | 143.25 | 101.99 | 155.02 | 102.99 | |||||
Receivables Turnover (Average Receivables) | 217.8 | 196.37 | 148.25 | 102.16 | 72.32 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.4 | 1.21 | 1.24 | 1.47 | 1.81 | |||||
Quick Ratio | 0.69 | 0.55 | 0.52 | 0.6 | 1.01 | |||||
Operating Cash Flow to Current Liabilities | 1.96 | 0.35 | 0.02 | -1.34 | -1.74 | |||||
Days Sales Outstanding (Average Receivables) | 1.68 | 1.86 | 2.46 | 3.58 | 5.05 | |||||
Average Days Payable Outstanding | 8.87 | 14.88 | 21.38 | 9.3 | 9.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 13.17 | 13.1 | 11.89 | 10.9 | 21.79 | |||||
Total Debt / Total Capital | 11.64 | 11.59 | 10.63 | 9.83 | 17.89 | |||||
LT Debt/Equity | 13.17 | 13.1 | 11.89 | 10.9 | 21.79 | |||||
Long-Term Debt / Total Capital | 11.64 | 11.59 | 10.63 | 9.83 | 17.89 | |||||
Total Liabilities / Total Assets | 95.81 | 96.25 | 96.06 | 96.32 | 96.2 | |||||
EBIT / Interest Expense | 38.08 | 12.69 | 14.19 | 13.49 | 14.9 | |||||
EBITDA / Interest Expense | 39.53 | 13.26 | 14.84 | 14.32 | 15.6 | |||||
(EBITDA - Capex) / Interest Expense | 36.97 | 10.96 | 12.5 | 11.45 | 13.33 | |||||
Total Debt / EBITDA | 0.92 | 1.1 | 0.98 | 1.02 | 1.46 | |||||
Net Debt / EBITDA | 0.49 | 0.49 | 0.35 | 0.31 | 0.9 | |||||
Total Debt / (EBITDA - Capex) | 0.99 | 1.33 | 1.17 | 1.27 | 1.71 | |||||
Net Debt / (EBITDA - Capex) | 0.53 | 0.59 | 0.41 | 0.38 | 1.05 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 299.24 | -25.17 | -20.64 | 81.96 | -21.34 | |||||
Gross Profit, 1 Yr. Growth % | -2.09 | 17.18 | 18.82 | -7.92 | 8.07 | |||||
EBITDA, 1 Yr. Growth % | 3.23 | -16.93 | 11.92 | -3.33 | 50.56 | |||||
EBITA, 1 Yr. Growth % | 4.48 | -16.69 | 11.85 | -4.81 | 52.67 | |||||
EBIT, 1 Yr. Growth % | 4.48 | -16.69 | 11.85 | -4.81 | 52.67 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -10.39 | -20.6 | 7.15 | 4.57 | 39.36 | |||||
Net Income, 1 Yr. Growth % | -10.39 | -20.6 | 7.15 | 4.57 | 39.36 | |||||
Normalized Net Income, 1 Yr. Growth % | 1.74 | -21.19 | 12.86 | -5.18 | 53.82 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -10.38 | -20.9 | 7.41 | 4.25 | 38.54 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.38 | 3.37 | 19.28 | 20.08 | 17.95 | |||||
Accounts Receivable, 1 Yr. Growth % | -22.14 | 68.57 | 26.08 | 85.83 | 43.87 | |||||
Total Assets, 1 Yr. Growth % | 39.22 | 12.53 | 4.67 | 16.86 | 5.1 | |||||
Common Equity, 1 Yr. Growth % | 26.3 | 0.53 | 10.17 | 9.07 | 8.44 | |||||
Tangible Book Value, 1 Yr. Growth % | 26.17 | 0.36 | 9.97 | 8.96 | 8.38 | |||||
Cash From Operations, 1 Yr. Growth % | -14.92 | -74.96 | -95.11 | -8.27T | 28.68 | |||||
Capital Expenditures, 1 Yr. Growth % | 27.04 | 124.05 | 2.13 | 22.77 | 9.36 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 20.39 | 67.91 | -56.38 | -256.77 | 9.97 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 24.66 | 70.72 | -53.55 | -229.01 | 7.6 | |||||
Dividend Per Share, 1 Yr. Growth % | 150 | -72.5 | 9.09 | 0 | 41.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 40.68 | 72.84 | -22.94 | 20.17 | 19.89 | |||||
Gross Profit, 2 Yr. CAGR % | -3.97 | 7.11 | 17.99 | 4.59 | -0.24 | |||||
EBITDA, 2 Yr. CAGR % | -2.04 | -6.96 | -3.58 | 4.02 | 20.64 | |||||
EBITA, 2 Yr. CAGR % | -1.77 | -6.7 | -3.47 | 3.19 | 20.55 | |||||
EBIT, 2 Yr. CAGR % | -1.77 | -6.7 | -3.47 | 3.19 | 20.55 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -8.37 | -15.65 | -7.76 | 5.85 | 20.72 | |||||
Net Income, 2 Yr. CAGR % | -8.37 | -15.65 | -7.76 | 5.85 | 20.72 | |||||
Normalized Net Income, 2 Yr. CAGR % | -2.19 | -10.46 | -5.69 | 3.45 | 20.77 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -8.43 | -15.8 | -7.82 | 5.82 | 20.18 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.73 | -2.15 | 11.04 | 19.68 | 19.01 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.75 | 14.57 | 45.78 | 53.07 | 63.51 | |||||
Total Assets, 2 Yr. CAGR % | 15.41 | 25.16 | 8.53 | 10.6 | 10.82 | |||||
Common Equity, 2 Yr. CAGR % | 13.73 | 12.68 | 5.24 | 9.62 | 8.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.66 | 12.53 | 5.05 | 9.46 | 8.67 | |||||
Cash From Operations, 2 Yr. CAGR % | -19.82 | -53.85 | -88.94 | 99.87 | 925.57 | |||||
Capital Expenditures, 2 Yr. CAGR % | -13.4 | 68.71 | 51.27 | 11.98 | 15.87 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 31.12 | 42.18 | -14.42 | -17.3 | 31.3 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 30.64 | 45.89 | -10.95 | -22.59 | 17.82 | |||||
Dividend Per Share, 2 Yr. CAGR % | -20.32 | -17.08 | -45.23 | 4.45 | 19.02 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 28.8 | 13.98 | 33.34 | 2.62 | 4.49 | |||||
Gross Profit, 3 Yr. CAGR % | 0.67 | 2.62 | 10.88 | 8.63 | 5.74 | |||||
EBITDA, 3 Yr. CAGR % | -11.86 | -6.99 | -1.05 | -3.5 | 17.66 | |||||
EBITA, 3 Yr. CAGR % | -12.26 | -7.02 | -0.89 | -3.92 | 17.58 | |||||
EBIT, 3 Yr. CAGR % | -12.26 | -7.02 | -0.89 | -3.92 | 17.58 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -16.1 | -12.65 | -8.64 | -3.82 | 16.02 | |||||
Net Income, 3 Yr. CAGR % | -16.1 | -12.65 | -8.64 | -3.82 | 16.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.8 | -8.98 | -3.27 | -5.52 | 18.07 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -16.14 | -12.79 | -8.68 | -3.96 | 15.76 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.96 | -1.42 | 4.53 | 13.98 | 19.1 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.92 | 21.18 | 18.28 | 58.07 | 49.94 | |||||
Total Assets, 3 Yr. CAGR % | 15.27 | 14.44 | 17.92 | 11.24 | 8.73 | |||||
Common Equity, 3 Yr. CAGR % | 9.8 | 9.15 | 11.84 | 6.5 | 9.23 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.78 | 9.04 | 11.67 | 6.34 | 9.1 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.73 | -45.6 | -78.17 | 0.01 | 72.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.44 | 18.89 | 42.72 | 41.1 | 11.1 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -44.99 | 42.39 | -4.11 | 4.72 | -9.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -44.42 | 42.83 | -0.38 | 0.76 | -13.61 | |||||
Dividend Per Share, 3 Yr. CAGR % | -23.69 | -44.11 | -9.14 | -33.06 | 15.62 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 31.93 | 10.47 | 4.88 | 16.42 | 27.79 | |||||
Gross Profit, 5 Yr. CAGR % | 2.38 | 3.14 | 7.27 | 3.4 | 6.29 | |||||
EBITDA, 5 Yr. CAGR % | -7.43 | -10.59 | -8.46 | -2.73 | 7.12 | |||||
EBITA, 5 Yr. CAGR % | -7.67 | -10.83 | -8.85 | -3.06 | 7.19 | |||||
EBIT, 5 Yr. CAGR % | -7.67 | -10.83 | -8.85 | -3.06 | 7.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -10.34 | -14.7 | -12.86 | -5.67 | 2.13 | |||||
Net Income, 5 Yr. CAGR % | -10.34 | -14.7 | -12.86 | -5.67 | 2.13 | |||||
Normalized Net Income, 5 Yr. CAGR % | -8.04 | -12.4 | -10.02 | -4.2 | 5.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -10.39 | -14.8 | -12.91 | -5.77 | 1.92 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.89 | 18.18 | 5.5 | 6.53 | 10.09 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.63 | 9.5 | 16.92 | 33.05 | 34.64 | |||||
Total Assets, 5 Yr. CAGR % | 15.7 | 14.4 | 12.53 | 12.89 | 15.03 | |||||
Common Equity, 5 Yr. CAGR % | 11.34 | 7.41 | 7.95 | 9.34 | 10.6 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.37 | 7.38 | 7.86 | 9.21 | 10.46 | |||||
Cash From Operations, 5 Yr. CAGR % | 15.01 | -15.01 | -56.42 | -8.45 | 1.83 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.71 | 28.62 | 22.51 | 16.07 | 31.31 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -9.28 | 46.47 | -34.35 | 14.57 | 8.74 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.79 | 46.1 | -32.88 | 11.79 | 6.53 | |||||
Dividend Per Share, 5 Yr. CAGR % | -14.59 | -30.53 | -33.17 | -28.23 | 1.22 |
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition